Administration of PIP/56-1 or PIP/56-2 effectively suppressed the growth of AML cells with high GPR56 expression but not AML cells with low GPR56 expression (Fig. 5a–d). The gene discussed is ADGRG1; the disease is acute myeloid leukemia.